MedWatch

Audientes halves 2022 revenue goal

With a new ambition to generate DKK 9–12m (USD 1.2–1.6m) in sales in 2022, the hearing firm has cut its prior projection in half.

Steen Thygesen, CEO of Audientes | Photo: Audientes / PR

Over half way through 2022, Danish hearing firm Audientes is dialing down its financial expectations for the full-year.

Concretely, the firm has adjusted its outlook for year-ending revenue to DKK 9–12m (USD 1.2–1.6m), less than half on average of the former goal of booking DKK 23–27m (USD 3.2–3.7m) in 2022. The operating result (EBITDA) has also been changed to a deficit around DKK 10–12m (USD 1.4–1.6m) from previous estimated deficit of DKK 13–15m (USD 1.8–2.1m).

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs